Yifeng Ebit from 2010 to 2024

603939 Stock   22.56  1.40  5.84%   
Yifeng Pharmacy's EBIT is increasing over the years with slightly volatile fluctuation. Overall, EBIT is expected to go to about 2.3 B this year. From 2010 to 2024 Yifeng Pharmacy EBIT quarterly data regression line had arithmetic mean of  826,461,392 and r-squared of  0.82. View All Fundamentals
 
EBIT  
First Reported
2018-06-30
Previous Quarter
606.6 M
Current Value
472 M
Quarterly Volatility
132.7 M
 
Covid
Check Yifeng Pharmacy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Yifeng Pharmacy's main balance sheet or income statement drivers, such as Interest Expense of 168.6 M, Selling General Administrative of 5.9 B or Total Revenue of 23.7 B, as well as many indicators such as . Yifeng financial statements analysis is a perfect complement when working with Yifeng Pharmacy Valuation or Volatility modules.
  
This module can also supplement various Yifeng Pharmacy Technical models . Check out the analysis of Yifeng Pharmacy Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Yifeng Stock

Yifeng Pharmacy financial ratios help investors to determine whether Yifeng Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yifeng with respect to the benefits of owning Yifeng Pharmacy security.